Kythera Biopharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 20   

Articles published

KYTH 36.33 +0.51 (1.42%)
price chart
Kythera Biopharmaceuticals, Inc. (KYTH) in Focus: Stock Surges 9.9 %
Kythera Biopharmaceuticals, Inc. (KYTH - Snapshot Report) was a big mover last session, as the company saw its shares rise nearly 10% on the day.
Related articles »  
Drug Most Volatile: Intercept Pharmaceuticals (NASDAQ:ICPT), Retrophin ...
Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) shares moved up 9.94% in last trading session and was closed at $35.82, while trading in range of $31.46 - $36.05.
Related articles »  
Health Care Equities Analysis -- Research on Raptor Pharma, Intercept Pharma ...
(NASDAQ:RPTP) , Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) , KYTHERA Biopharmaceuticals Inc. (NASDAQ:KYTH) and Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) .
Related articles »  
KYTHERA Biopharmaceuticals Announces 2013 Operating Results
CALABASAS, Mar 17, 2014 (GLOBE NEWSWIRE via COMTEX) -- KYTHERA Biopharmaceuticals, Inc. (NASDAQ:KYTH) today reported financial results for its quarter and year ended December 31, 2013, and provided an update on recent accomplishments.
Related articles »  
Insider Selling: Keith R. Leonard Sells 13260 Shares of KYTHERA ...
KYTHERA Biopharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market.
KYTHERA Biopharmaceuticals Trading Down 5.1% After Insider Selling (KYTH)
KYTHERA Biopharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market.
Related articles »  
KYTHERA Biopharmaceuticals Stock Price Down 9.1% on Insider Selling (KYTH)
KYTHERA Biopharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market.
Related articles »  
Drug Manufacturer Most Volatile: Zogenix (NASDAQ:ZGNX), Alimera Sciences ...
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) shares moved down -5.95% in last trading session and was closed at $35.90, while trading in range of $34.40-$38.96.
What Falling Estimates amp; Price Mean for Kythera (KYTH)
One such stock that you may want to consider dropping is Kythera Biopharmaceuticals, Inc. (KYTH - Snapshot Report), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the ...
Related articles »  
The Top Life Sciences Investors Of 2014
Recent additions to Byers' collection of exits are VeraCyte Inc. (IPO 2013), Foundation Medicine Inc. (IPO 2013), Five Prime Therapeutics Inc. (IPO 2013), Pacific Biosciences of California Inc. (IPO 2010), OptiMedica Corp. ... A University of Puget ...
Related articles »